at german pharma for mack she's the 1st woman to single handedly run a daks company let's talk about that with stephanie low how she's director of the european academy for female leadership stephanie are we finally seeing some sort of change. well yes we actually do i mean germany has been so conservative for a long time and i do believe that in the past 10 years things have changed it has been a generational change but also or like a lot of activists and we had this huge debates about and he made leadership lack a female role models in power positions and i do believe that this is time to change and one of the arguments here was a lack of female candidates is there any truth to that i mean in the u.s. we see all of these female tech entrepreneurs in fantastic positions but not here in germany. well it depends on how you view it i would say 1st of all it is an excuse i mean if you look at the number for example of women studying computer science the numbers in the u.s. are not high and then in germany at all but i think what you can say is that there has that women have not been prom

at german pharma merck now of pharma firm she's the 1st woman to single handedly run a company and the 1st woman c.e.o. in america's 350 year history good news for america studies show companies with diverse leadership are more profitable but female executives in germany are missing men dominate boardrooms of listen companies here with a total of $614.00 seats women occupy $86.00 seats germany is lagging now in the u.s. women occupied more than a quarter of boardroom seats and the largest corporations almost the same case in the u.k. and germany women only hold 16 percent of boardroom seats now those figures are from the right foundation a nonprofit organization promoting women and diversity in executive roles i'm joined by they rector of the foundation that kristen bell come to the program ok to get this out of the way you of course are heading up an organization jointly that wants to promote women women in leadership so you are a man is this not emblematic of the situation we're talking about. well an abandoned her parent organization together with a woman's were a man and a woman we

at german pharma mark malloch of pharma firm she's the 1st woman to single handedly run a company and the 1st woman c.e.o. in america's 350 year history good news for america studies show companies with diverse leadership are more profitable but female executives in germany are missing men dominate boardrooms of list of companies here with a total of $614.00 seats women occupy $86.00 seats germany is lagging now in the u.s. women occupied more than a quarter of boardroom seats and the largest corporations almost the same case in the u.k. and germany women only hold 16 percent of boardroom seats now those figures are from the right foundation a nonprofit organization promoting women and diversity in executive roles i'm joined by they rector of the foundation that kristen bell welcome to the program ok i have to get this out of the way you of course are heading up an organization jointly that wants to promote women women in leadership so you are a man is this not of the magic of the situation we're talking about. the decision together with a woman's work done on the woman we need to get

a proud achievement for the german company that went from startup to pharma superstar. now the german government is siding with drugmakers, saying the protection of intellectual property is a source of innovation and must remain so in the future, so the -- through the manufacture and high production capacity of vaccines, not through patent waivers. in a jab at the biden administration, the german health minister had this to say -- >> if the real problem is not patents, production capacity, and availability, i would be delighted if the united states is willing to allow the export of doses manufactured there just like the european union. >> the u.s. is just one of the wealthy nations accused of vaccine hoarding, extending their immunization programs far beyond their vulnerable populations while poorer nations go without. the pharma industry says that problem should be fixed first. >> what we need to do is tackle the real problems. we need to look at barriers which are hindering the ramng up of supplies, and we need to improve the efficiency. the patent would not give you a

a joint investigation by several european media outlets shows pharma german chancellor candidate past i am book was one of the be enough targets. he's angry at the revelation saying it's pretty grotesque that allied intelligence service a spy on leading politicians of other countries. it's evidence that they have a life of their own. i think this is a political scandal. the phone tapping of chancellor angela macklin form a foreign minister. frank, lighter stein maya came out in 2013 as part of whistleblower. edward snowden leaks on the n s a securities. what they didn't reveal was that such a close european ally was involved in another major problem. the danish government didn't inform their german neighbors, though they apparently knew about the east dropping as early as 2015. the german government only found out about the latest revelations from the press. after a virtual meeting, both terms, le, le, mackerel and french president demand when michael emphasized why a tapping allies was not acceptable. you know me has always thought i was relief to hear that the danish government, the

eavesdrop on european politicians and joined investigation by several european media outlets shows pharma german chancellor candidate pastime book was one of the be enough targets. he's angry at the revelation saying it's pretty grotesque that allied intelligence services spy on leading politicians of other countries. it's evidence that they have a life of their own. i think this is a political scandal. the phone tapping of chance. le le macklin, former foreign minister find the vital stein my, came out in 2013, as part of whistleblower. edward snowden leaks on the n. s. a 's active a t's. what they didn't reveal was that such a close european l. i was involved in another major problem. the danish government didn't inform their german neighbors, though they apparently knew about the east dropping as early as 2015 to those who were involved in the original investigation into the n. s a scandal. this hasn't come as a price. that's why i always pointed out, we have interest. we have common interests. but there is no field of friendship concerning states or agencies. friendship you have from between

and joined investigation by several european media outlets shows pharma german chancellor candidates past. i am book was one of the be enough targets. he's angry at the revelation saying it's pretty grotesque that allied intelligence services spy on leading politicians of other countries. it's evidence that they have a life of their own. i think this is a political scandal. the phone tapping off. chance le le macklin, former foreign minister, firefighter stein my, came out in 2013, as part of whistleblower edward snowden leaks on the 8th activities. what they didn't reveal was that such a close european ally was involved. another major problem, the danish government didn't inform their german neighbors, though they apparently knew about the east dropping as early as 2015 to those who were involved in the original investigation into the n. s a scandal. this hasn't come as, as a price. that's why i always pointed out, we have interests, we have common interests, but there is no field of friendship concerning states or agencies. friendship you have from between person, but not between a

a joint investigation by several european media outlets shows pharma german chancellor candidate pastime book was one of the be enough targets. he's angry at the revelation saying it's pretty grotesque that allied intelligence service a spy on leading politicians of other countries. it's evidence that they have a life of their own. i think this is a political scandal. the phone tapping of chance. langley, la macklin, former foreign minister, firefighter. stine my, came out in 2013, as part of whistleblower edward snowden leaks on the n. s. a sec to tease what they didn't reveal was that such a close european ally was involved. another major problem, the danish government didn't inform their german neighbors, though they apparently knew about the east dropping as early as 2015. the german government only found out about the latest revelations from the press. after a virtual meeting, both terms la la macklin, french president, demand what am i call? emphasized wiretapping allies was not acceptable. let me check. so we still, i was relief to hear that the janus government, the dentist, defe

biotech pfizer was 1st out of the gate a proud a chief meant for biotech the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again spun had this to say the least if the real product isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations while poo

government but our government doesn't the german government said intellectual property is a source of innovation pharma companies that have invested billions into developing these do they have a point. yes but the german public's the german taxpayers have invested a lot in those companies so we have helped them to invent all these very very important vaccines and we don't want to cancel intellectual property rights at all it is just about covert 19 vaccines and i think this would be a very good and very important step but finds is already selling their vaccine cheaper to low income countries on a nonprofit basis don't you think that's enough. i'm on the side of india of south africa of over 100 countries of important organizations like doctors without borders and so on i think you could wait to see some gifts from companies but you can make decisions too and this is what states are about and this is what sort of all trade organization is about and i i really cannot imagine that the german government would block such such an action if the u.s. government is supporting it stephanie is there a member of t

antec pfizer was 1st out of the gate a proud achievement for buy on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on proving 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again sean had this to say the least if the real product it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations while

antec pfizer was 1st out of the gate a proud a chief meant for by on tech the german company that went from start up to pharma superstar now in the debate over waiving patents on 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again spun had this to say the least if the real problem it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export folks who get. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations while poor

antec pfizer was 1st out of the gate a proud a chief meant for by on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and in a jab at the biden administration german health minister again spun had this to say the least if the real problem it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations w

a joint investigation by several european media outlets shows pharma german chancellor candidate pastime book was one of the be enough targets. he's angry at the revelation saying it's pretty grotesque that allied intelligence service a spy on leading politicians of other countries. it's evidence that they have a life of their own. i think this is a political scandal. the phone tapping of chance. le le macklin, former foreign minister find the vital stein my, came out in 2013. as part of whistleblower. edward snowden leaks on the n s a securities. what they didn't reveal was that such a close european l. i was involved in another major problem. the danish government didn't inform their german neighbors, though they apparently knew about the east dropping as early as 2015 to those who were involved in the original investigation into the n. s a scandal. this hasn't come as a surprise. that's why i always pointed out, we have interest, we have common interests, but there is no field of friendship concerning states or agencies. friendship you have from between person, but not between agency.

biotech pfizer was 1st out of the gate a proud achievement for buy on tech the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again spun had this to say the least if the real problem isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. see it was indeed it was an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populat

government but our government doesn't the german government said intellectual property is a source of innovation pharma companies that have invested billions into developing these do they have a point. yes but the german public's the german taxpayers have invested a lot in those companies so we have helped them to invent all these very very important vaccines and we don't want to cancel intellectual property rights at all it is just about covert 19 vaccines and i think this would be a very good and very important step well finds is already selling their vaccine cheaper to low income countries on a non profit basis don't you think that's enough. i'm on the side of india of south africa of over 100 countries of important organizations like doctors without borders and so on i think you could debate to to some gifts from companies but you can make decisions too and this is what states are about and this is what sort of all trade organization is about and i i really cannot imagine that the german government would block such. an action if the u.s. government is supporting it stephanie a member of the part an

tax pfizer was 1st out of the gate a proud she had meant for by on tech the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and in a jab at the biden administration german health minister again spawn had this to say the least if the real problem isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations whi

tax finds her was 1st out of the gate a proud achievement for buy on tack the german company that went from start up to pharma superstar now in the debate over waving patents on proven 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents. germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again spun had this to say the least if the real problem it isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was until it was an export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations w

earlier this morning, german chancellor angela merkel came out in opposition of the plan to release patents. that boosted pharmaer had been down 12% before her comments known half a percent decline this company was at 1.20 during the early part of the pandemic last year making it one of the fastest runners in the stay-at-home trade >> fastly, fed rinne, rocket, and etsy all down up to 25%, in fastly's case. time for a cnbc news update with rahel solomon. hi, rahel. >> hello good to see you. here's what's happening at this hour, everyone >> a government says u.s. support of waivers is a significant step but many questions remain about how to improve global access to more vaccines a new poll shows tepid support for vaccinating children the kaiser foundation 30% of parents with kids ages 12 to 15 will get them vaccinated as soon as shots become available. 26% are taking a wait and see approach 18% say they will only do it if schools require the shots. one in four say they will definitely not get their kids vaccinated. >>> this is sweet n holiday anderson, researchers trained bes to detect the coronavirus. test res

we just heard from the head of pharma who pushed back and the german health minister is saying that theberations would likely take months. these stocks sold off yesterday. do you believe the u.s. move will have an impact on pharmaceutical companies? what's your take on this group as we also wonder what will happen in terms of drug pricing as well. >> good morning, maria. yeah, it's going to have a major impact on the drug industry. it's also going to have a major impact on business in general. you know, when you look at it, these drug companies, pharmaceutical companies, they're backed by investors like myself early on in the hope of having some breakthrough drug that might make a lot of money for the company and for the investors. if the administration is going to say that you create a great product, we're going to take it from you unilaterally and spread it across the world in some instances to china, to india, and you're not going to profit from it, the investment goes away in these companies and these companies cease to exist. when you look at a company like moderna, maria, they've

pharma companies. it could be a long process. you see that share price reaction in this german biotech business.the eu chamber of commerce. more on that conversation. they have a lot to say on the china relationship. that is next. this is bloomberg. ♪ >> it is that makes of positive markets, high volatility and no dislocations. overall, an appetite for investors with inflation trades. activities on the corporate side, also. a lot of elements were aligned to help less. -- help us. we saw the bmi index which was at the highest level since 1997, services are more impacted these days with the lockdowns. vaccinations make progress and we are positive the economy will open. it will help your -- help europe. anna: that was socgen ceo. they had their best trading revenue in years. that was pushing the share prices higher and continues to do so. that stock is up 4.7%. the european union will not -- eu sanctions on chinese officials over alleged abuse in the shanghai region. they also strategizing ways to counter takeovers. for more on that eu-china relationship is our brussels correspondent maria tadeo.

by on tax pfizer was 1st out of the gate a proud a chief metric by on tac the german company that went from start up to pharma superstar now in the debate over waving. in 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents germany says industry and government should work on transferring technology to new manufacturers if they want to scale up vaccine production quickly and jab at the biden administration german health minister again spawn had this to say the least if the real problem isn't patents but production capacity and availability then i'd be delighted if the united states is now willing to allow the export of doses manufactured there just like the european union. was indeed and was often export fights with. the us is just one of the wealthy nations accused of vaccine hoarding extending their immunization programs far beyond their vulnerable populations while poorer

on tax pfizer was 1st out of the gate a proud a chief meant for by on tac the german company that went from start up to pharma superstar now in the debate over waiving patents on covert 1000 vaccines the german government is siding with drug makers saying the protection of intellectual property is a source of innovation and must remain so in the future the limiting factor in the production of vaccines our production capacities and the high quality standards not the patents germany says industry and government should work on.